Twin Tree Management, LP Repligen Corp Put Options Transaction History

Twin Tree Management, LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 09, 2024	BUY	$170.78 - $208.42 $2.73 Million - $3.33 Million	16,000 New	16,000 $2.94 Million
Q2 2022 Aug 11, 2022	SELL	$140.68 - $188.02 $10.9 Million - $14.5 Million	-77,300 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$161.19 - $257.96 $2.61 Million - $4.18 Million	16,200 Added 26.51%	77,300 $14.5 Million
Q4 2021 Feb 10, 2022	SELL	$247.59 - $304.47 $3 Million - $3.68 Million	-12,100 Reduced 16.53%	61,100 $16.2 Million
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $14.3 Million - $23.7 Million	73,200 New	73,200 $21.2 Million
Q3 2020 Nov 13, 2020	SELL	$122.51 - $158.27 $490,040 - $633,080	-4,000 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$84.96 - $109.14 $339,840 - $436,560	4,000 New	4,000 $386,000

486

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.